Hospital Furniture
Hospital Furniture market is segmented by players, region (country), by Type and by Application. ... Read More
Global Follicle Stimulating Hormone Market Insights and Forecast to 2028
1 Study Coverage
1.1 Follicle Stimulating Hormone Product Introduction
1.2 Market by Type
1.2.1 Global Follicle Stimulating Hormone Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Recombinant FSH
1.2.3 Urinary FSH
1.3 Market by Application
1.3.1 Global Follicle Stimulating Hormone Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Follicle Stimulating Hormone Sales Estimates and Forecasts 2017-2028
2.2 Global Follicle Stimulating Hormone Revenue Estimates and Forecasts 2017-2028
2.3 Global Follicle Stimulating Hormone Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Follicle Stimulating Hormone Sales by Region
2.4.1 Global Follicle Stimulating Hormone Sales by Region (2017-2022)
2.4.2 Global Sales Follicle Stimulating Hormone by Region (2023-2028)
2.5 Global Follicle Stimulating Hormone Revenue by Region
2.5.1 Global Follicle Stimulating Hormone Revenue by Region (2017-2022)
2.5.2 Global Follicle Stimulating Hormone Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Follicle Stimulating Hormone Sales by Manufacturers
3.1.1 Global Top Follicle Stimulating Hormone Manufacturers by Sales (2017-2022)
3.1.2 Global Follicle Stimulating Hormone Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Follicle Stimulating Hormone in 2021
3.2 Global Follicle Stimulating Hormone Revenue by Manufacturers
3.2.1 Global Follicle Stimulating Hormone Revenue by Manufacturers (2017-2022)
3.2.2 Global Follicle Stimulating Hormone Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Follicle Stimulating Hormone Revenue in 2021
3.3 Global Follicle Stimulating Hormone Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Follicle Stimulating Hormone Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Follicle Stimulating Hormone Sales by Type
4.1.1 Global Follicle Stimulating Hormone Historical Sales by Type (2017-2022)
4.1.2 Global Follicle Stimulating Hormone Forecasted Sales by Type (2023-2028)
4.1.3 Global Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
4.2 Global Follicle Stimulating Hormone Revenue by Type
4.2.1 Global Follicle Stimulating Hormone Historical Revenue by Type (2017-2022)
4.2.2 Global Follicle Stimulating Hormone Forecasted Revenue by Type (2023-2028)
4.2.3 Global Follicle Stimulating Hormone Revenue Market Share by Type (2017-2028)
4.3 Global Follicle Stimulating Hormone Price by Type
4.3.1 Global Follicle Stimulating Hormone Price by Type (2017-2022)
4.3.2 Global Follicle Stimulating Hormone Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Follicle Stimulating Hormone Sales by Application
5.1.1 Global Follicle Stimulating Hormone Historical Sales by Application (2017-2022)
5.1.2 Global Follicle Stimulating Hormone Forecasted Sales by Application (2023-2028)
5.1.3 Global Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
5.2 Global Follicle Stimulating Hormone Revenue by Application
5.2.1 Global Follicle Stimulating Hormone Historical Revenue by Application (2017-2022)
5.2.2 Global Follicle Stimulating Hormone Forecasted Revenue by Application (2023-2028)
5.2.3 Global Follicle Stimulating Hormone Revenue Market Share by Application (2017-2028)
5.3 Global Follicle Stimulating Hormone Price by Application
5.3.1 Global Follicle Stimulating Hormone Price by Application (2017-2022)
5.3.2 Global Follicle Stimulating Hormone Price Forecast by Application (2023-2028)
6 North America
6.1 North America Follicle Stimulating Hormone Market Size by Type
6.1.1 North America Follicle Stimulating Hormone Sales by Type (2017-2028)
6.1.2 North America Follicle Stimulating Hormone Revenue by Type (2017-2028)
6.2 North America Follicle Stimulating Hormone Market Size by Application
6.2.1 North America Follicle Stimulating Hormone Sales by Application (2017-2028)
6.2.2 North America Follicle Stimulating Hormone Revenue by Application (2017-2028)
6.3 North America Follicle Stimulating Hormone Market Size by Country
6.3.1 North America Follicle Stimulating Hormone Sales by Country (2017-2028)
6.3.2 North America Follicle Stimulating Hormone Revenue by Country (2017-2028)
7 Europe
7.1 Europe Follicle Stimulating Hormone Market Size by Type
7.1.1 Europe Follicle Stimulating Hormone Sales by Type (2017-2028)
7.1.2 Europe Follicle Stimulating Hormone Revenue by Type (2017-2028)
7.2 Europe Follicle Stimulating Hormone Market Size by Application
7.2.1 Europe Follicle Stimulating Hormone Sales by Application (2017-2028)
7.2.2 Europe Follicle Stimulating Hormone Revenue by Application (2017-2028)
7.3 Europe Follicle Stimulating Hormone Market Size by Country
7.3.1 Europe Follicle Stimulating Hormone Sales by Country (2017-2028)
7.3.2 Europe Follicle Stimulating Hormone Revenue by Country (2017-2028)
7.3.3 Poland
8 Asia Pacific
8.1 Asia Pacific Follicle Stimulating Hormone Market Size by Type
8.1.1 Asia Pacific Follicle Stimulating Hormone Sales by Type (2017-2028)
8.1.2 Asia Pacific Follicle Stimulating Hormone Revenue by Type (2017-2028)
8.2 Asia Pacific Follicle Stimulating Hormone Market Size by Application
8.2.1 Asia Pacific Follicle Stimulating Hormone Sales by Application (2017-2028)
8.2.2 Asia Pacific Follicle Stimulating Hormone Revenue by Application (2017-2028)
8.3 Asia Pacific Follicle Stimulating Hormone Market Size by Region
8.3.1 Asia Pacific Follicle Stimulating Hormone Sales by Region (2017-2028)
8.3.2 Asia Pacific Follicle Stimulating Hormone Revenue by Region (2017-2028)
9 Latin America
9.1 Latin America Follicle Stimulating Hormone Market Size by Type
9.1.1 Latin America Follicle Stimulating Hormone Sales by Type (2017-2028)
9.1.2 Latin America Follicle Stimulating Hormone Revenue by Type (2017-2028)
9.2 Latin America Follicle Stimulating Hormone Market Size by Application
9.2.1 Latin America Follicle Stimulating Hormone Sales by Application (2017-2028)
9.2.2 Latin America Follicle Stimulating Hormone Revenue by Application (2017-2028)
9.3 Latin America Follicle Stimulating Hormone Market Size by Country
9.3.1 Latin America Follicle Stimulating Hormone Sales by Country (2017-2028)
9.3.2 Latin America Follicle Stimulating Hormone Revenue by Country (2017-2028)
10 Middle East and Africa
10.1 Middle East and Africa Follicle Stimulating Hormone Market Size by Type
10.1.1 Middle East and Africa Follicle Stimulating Hormone Sales by Type (2017-2028)
10.1.2 Middle East and Africa Follicle Stimulating Hormone Revenue by Type (2017-2028)
10.2 Middle East and Africa Follicle Stimulating Hormone Market Size by Application
10.2.1 Middle East and Africa Follicle Stimulating Hormone Sales by Application (2017-2028)
10.2.2 Middle East and Africa Follicle Stimulating Hormone Revenue by Application (2017-2028)
10.3 Middle East and Africa Follicle Stimulating Hormone Market Size by Country
10.3.1 Middle East and Africa Follicle Stimulating Hormone Sales by Country (2017-2028)
10.3.2 Middle East and Africa Follicle Stimulating Hormone Revenue by Country (2017-2028)
11 Company Profiles
11.1 Merck Serono
11.1.1 Merck Serono Corporation Information
11.1.2 Merck Serono Overview
11.1.3 Merck Serono Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Serono Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Serono Recent Developments
11.2 MSD
11.2.1 MSD Corporation Information
11.2.2 MSD Overview
11.2.3 MSD Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 MSD Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 MSD Recent Developments
11.3 IBSA
11.3.1 IBSA Corporation Information
11.3.2 IBSA Overview
11.3.3 IBSA Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 IBSA Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 IBSA Recent Developments
11.4 Ferring
11.4.1 Ferring Corporation Information
11.4.2 Ferring Overview
11.4.3 Ferring Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ferring Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ferring Recent Developments
11.5 Livzon
11.5.1 Livzon Corporation Information
11.5.2 Livzon Overview
11.5.3 Livzon Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Livzon Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Livzon Recent Developments
11.6 Techwell
11.6.1 Techwell Corporation Information
11.6.2 Techwell Overview
11.6.3 Techwell Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Techwell Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Techwell Recent Developments
11.7 GenSci
11.7.1 GenSci Corporation Information
11.7.2 GenSci Overview
11.7.3 GenSci Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GenSci Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GenSci Recent Developments
11.8 Gedeon Richter
11.8.1 Gedeon Richter Corporation Information
11.8.2 Gedeon Richter Overview
11.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Gedeon Richter Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Gedeon Richter Recent Developments
11.9 Teva
11.9.1 Teva Corporation Information
11.9.2 Teva Overview
11.9.3 Teva Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Teva Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Teva Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Follicle Stimulating Hormone Industry Chain Analysis
12.2 Follicle Stimulating Hormone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Follicle Stimulating Hormone Production Mode & Process
12.4 Follicle Stimulating Hormone Sales and Marketing
12.4.1 Follicle Stimulating Hormone Sales Channels
12.4.2 Follicle Stimulating Hormone Distributors
12.5 Follicle Stimulating Hormone Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Follicle Stimulating Hormone Industry Trends
13.2 Follicle Stimulating Hormone Market Drivers
13.3 Follicle Stimulating Hormone Market Challenges
13.4 Follicle Stimulating Hormone Market Restraints
14 Key Findings in The Global Follicle Stimulating Hormone Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Follicle Stimulating Hormone Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Recombinant FSH
Table 3. Major Manufacturers of Urinary FSH
Table 4. Global Follicle Stimulating Hormone Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Follicle Stimulating Hormone Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Follicle Stimulating Hormone Sales by Region (2017-2022) & (K Doses)
Table 7. Global Follicle Stimulating Hormone Sales Market Share by Region (2017-2022)
Table 8. Global Follicle Stimulating Hormone Sales by Region (2023-2028) & (K Doses)
Table 9. Global Follicle Stimulating Hormone Sales Market Share by Region (2023-2028)
Table 10. Global Follicle Stimulating Hormone Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Follicle Stimulating Hormone Revenue Market Share by Region (2017-2022)
Table 12. Global Follicle Stimulating Hormone Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Follicle Stimulating Hormone Revenue Market Share by Region (2023-2028)
Table 14. Global Follicle Stimulating Hormone Sales by Manufacturers (2017-2022) & (K Doses)
Table 15. Global Follicle Stimulating Hormone Sales Share by Manufacturers (2017-2022)
Table 16. Global Follicle Stimulating Hormone Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Follicle Stimulating Hormone Revenue Share by Manufacturers (2017-2022)
Table 18. Follicle Stimulating Hormone Price by Manufacturers (2017-2022) &(USD/Dose)
Table 19. Global Follicle Stimulating Hormone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Follicle Stimulating Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Follicle Stimulating Hormone as of 2021)
Table 21. Follicle Stimulating Hormone Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Follicle Stimulating Hormone Product Offered
Table 23. Date of Manufacturers Enter into Follicle Stimulating Hormone Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
Table 26. Global Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
Table 27. Global Follicle Stimulating Hormone Sales Share by Type (2017-2022)
Table 28. Global Follicle Stimulating Hormone Sales Share by Type (2023-2028)
Table 29. Global Follicle Stimulating Hormone Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Follicle Stimulating Hormone Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Follicle Stimulating Hormone Revenue Share by Type (2017-2022)
Table 32. Global Follicle Stimulating Hormone Revenue Share by Type (2023-2028)
Table 33. Follicle Stimulating Hormone Price by Type (2017-2022) & (USD/Dose)
Table 34. Global Follicle Stimulating Hormone Price Forecast by Type (2023-2028) & (USD/Dose)
Table 35. Global Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
Table 36. Global Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
Table 37. Global Follicle Stimulating Hormone Sales Share by Application (2017-2022)
Table 38. Global Follicle Stimulating Hormone Sales Share by Application (2023-2028)
Table 39. Global Follicle Stimulating Hormone Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Follicle Stimulating Hormone Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Follicle Stimulating Hormone Revenue Share by Application (2017-2022)
Table 42. Global Follicle Stimulating Hormone Revenue Share by Application (2023-2028)
Table 43. Follicle Stimulating Hormone Price by Application (2017-2022) & (USD/Dose)
Table 44. Global Follicle Stimulating Hormone Price Forecast by Application (2023-2028) & (USD/Dose)
Table 45. North America Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
Table 46. North America Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
Table 47. North America Follicle Stimulating Hormone Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Follicle Stimulating Hormone Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
Table 50. North America Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
Table 51. North America Follicle Stimulating Hormone Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Follicle Stimulating Hormone Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Follicle Stimulating Hormone Sales by Country (2017-2022) & (K Doses)
Table 54. North America Follicle Stimulating Hormone Sales by Country (2023-2028) & (K Doses)
Table 55. North America Follicle Stimulating Hormone Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Follicle Stimulating Hormone Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
Table 58. Europe Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
Table 59. Europe Follicle Stimulating Hormone Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Follicle Stimulating Hormone Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
Table 62. Europe Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
Table 63. Europe Follicle Stimulating Hormone Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Follicle Stimulating Hormone Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Follicle Stimulating Hormone Sales by Country (2017-2022) & (K Doses)
Table 66. Europe Follicle Stimulating Hormone Sales by Country (2023-2028) & (K Doses)
Table 67. Europe Follicle Stimulating Hormone Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Follicle Stimulating Hormone Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
Table 70. Asia Pacific Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
Table 71. Asia Pacific Follicle Stimulating Hormone Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Follicle Stimulating Hormone Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
Table 74. Asia Pacific Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
Table 75. Asia Pacific Follicle Stimulating Hormone Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Follicle Stimulating Hormone Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Follicle Stimulating Hormone Sales by Region (2017-2022) & (K Doses)
Table 78. Asia Pacific Follicle Stimulating Hormone Sales by Region (2023-2028) & (K Doses)
Table 79. Asia Pacific Follicle Stimulating Hormone Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Follicle Stimulating Hormone Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
Table 82. Latin America Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
Table 83. Latin America Follicle Stimulating Hormone Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Follicle Stimulating Hormone Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
Table 86. Latin America Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
Table 87. Latin America Follicle Stimulating Hormone Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Follicle Stimulating Hormone Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Follicle Stimulating Hormone Sales by Country (2017-2022) & (K Doses)
Table 90. Latin America Follicle Stimulating Hormone Sales by Country (2023-2028) & (K Doses)
Table 91. Latin America Follicle Stimulating Hormone Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Follicle Stimulating Hormone Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
Table 94. Middle East and Africa Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
Table 95. Middle East and Africa Follicle Stimulating Hormone Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Follicle Stimulating Hormone Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
Table 98. Middle East and Africa Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
Table 99. Middle East and Africa Follicle Stimulating Hormone Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Follicle Stimulating Hormone Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Follicle Stimulating Hormone Sales by Country (2017-2022) & (K Doses)
Table 102. Middle East and Africa Follicle Stimulating Hormone Sales by Country (2023-2028) & (K Doses)
Table 103. Middle East and Africa Follicle Stimulating Hormone Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Follicle Stimulating Hormone Revenue by Country (2023-2028) & (US$ Million)
Table 105. Merck Serono Corporation Information
Table 106. Merck Serono Description and Major Businesses
Table 107. Merck Serono Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 108. Merck Serono Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Merck Serono Recent Developments
Table 110. MSD Corporation Information
Table 111. MSD Description and Major Businesses
Table 112. MSD Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 113. MSD Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. MSD Recent Developments
Table 115. IBSA Corporation Information
Table 116. IBSA Description and Major Businesses
Table 117. IBSA Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 118. IBSA Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. IBSA Recent Developments
Table 120. Ferring Corporation Information
Table 121. Ferring Description and Major Businesses
Table 122. Ferring Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 123. Ferring Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Ferring Recent Developments
Table 125. Livzon Corporation Information
Table 126. Livzon Description and Major Businesses
Table 127. Livzon Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 128. Livzon Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Livzon Recent Developments
Table 130. Techwell Corporation Information
Table 131. Techwell Description and Major Businesses
Table 132. Techwell Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 133. Techwell Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Techwell Recent Developments
Table 135. GenSci Corporation Information
Table 136. GenSci Description and Major Businesses
Table 137. GenSci Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 138. GenSci Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. GenSci Recent Developments
Table 140. Gedeon Richter Corporation Information
Table 141. Gedeon Richter Description and Major Businesses
Table 142. Gedeon Richter Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 143. Gedeon Richter Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Gedeon Richter Recent Developments
Table 145. Teva Corporation Information
Table 146. Teva Description and Major Businesses
Table 147. Teva Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 148. Teva Follicle Stimulating Hormone Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Teva Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Follicle Stimulating Hormone Distributors List
Table 153. Follicle Stimulating Hormone Customers List
Table 154. Follicle Stimulating Hormone Market Trends
Table 155. Follicle Stimulating Hormone Market Drivers
Table 156. Follicle Stimulating Hormone Market Challenges
Table 157. Follicle Stimulating Hormone Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Follicle Stimulating Hormone Product Picture
Figure 3. Global Follicle Stimulating Hormone Market Share by Type in 2021 & 2028
Figure 3. Recombinant FSH Product Picture
Figure 4. Urinary FSH Product Picture
Figure 5. Global Follicle Stimulating Hormone Market Share by Application in 2021 & 2028
Figure 6. Infertility Treatment
Figure 7. Assisted Reproductive Technology
Figure 8. Follicle Stimulating Hormone Report Years Considered
Figure 9. Global Follicle Stimulating Hormone Sales 2017-2028 (K Doses)
Figure 10. Global Follicle Stimulating Hormone Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Follicle Stimulating Hormone Revenue 2017-2028 (US$ Million)
Figure 12. Global Follicle Stimulating Hormone Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Follicle Stimulating Hormone Sales Market Share by Region (2017-2022)
Figure 14. Global Follicle Stimulating Hormone Sales Market Share by Region (2023-2028)
Figure 15. North America Follicle Stimulating Hormone Sales YoY (2017-2028) & (K Doses)
Figure 16. North America Follicle Stimulating Hormone Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Follicle Stimulating Hormone Sales YoY (2017-2028) & (K Doses)
Figure 18. Europe Follicle Stimulating Hormone Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Follicle Stimulating Hormone Sales YoY (2017-2028) & (K Doses)
Figure 20. Asia-Pacific Follicle Stimulating Hormone Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Follicle Stimulating Hormone Sales YoY (2017-2028) & (K Doses)
Figure 22. Latin America Follicle Stimulating Hormone Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Follicle Stimulating Hormone Sales YoY (2017-2028) & (K Doses)
Figure 24. Middle East & Africa Follicle Stimulating Hormone Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Follicle Stimulating Hormone Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Follicle Stimulating Hormone in the World: Market Share by Follicle Stimulating Hormone Revenue in 2021
Figure 27. Global Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
Figure 29. Global Follicle Stimulating Hormone Revenue Market Share by Type (2017-2028)
Figure 30. Global Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
Figure 31. Global Follicle Stimulating Hormone Revenue Market Share by Application (2017-2028)
Figure 32. North America Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
Figure 33. North America Follicle Stimulating Hormone Revenue Market Share by Type (2017-2028)
Figure 34. North America Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
Figure 35. North America Follicle Stimulating Hormone Revenue Market Share by Application (2017-2028)
Figure 36. North America Follicle Stimulating Hormone Sales Share by Country (2017-2028)
Figure 37. North America Follicle Stimulating Hormone Revenue Share by Country (2017-2028)
Figure 38. Europe Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
Figure 39. Europe Follicle Stimulating Hormone Revenue Market Share by Type (2017-2028)
Figure 40. Europe Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
Figure 41. Europe Follicle Stimulating Hormone Revenue Market Share by Application (2017-2028)
Figure 42. Europe Follicle Stimulating Hormone Sales Share by Country (2017-2028)
Figure 43. Europe Follicle Stimulating Hormone Revenue Share by Country (2017-2028)
Figure 44. Poland Follicle Stimulating Hormone Revenue (2017-2028) & (US$ Million)
Figure 45. Asia Pacific Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
Figure 46. Asia Pacific Follicle Stimulating Hormone Revenue Market Share by Type (2017-2028)
Figure 47. Asia Pacific Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
Figure 48. Asia Pacific Follicle Stimulating Hormone Revenue Market Share by Application (2017-2028)
Figure 49. Asia Pacific Follicle Stimulating Hormone Sales Share by Region (2017-2028)
Figure 50. Asia Pacific Follicle Stimulating Hormone Revenue Share by Region (2017-2028)
Figure 51. Latin America Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
Figure 52. Latin America Follicle Stimulating Hormone Revenue Market Share by Type (2017-2028)
Figure 53. Latin America Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
Figure 54. Latin America Follicle Stimulating Hormone Revenue Market Share by Application (2017-2028)
Figure 55. Latin America Follicle Stimulating Hormone Sales Share by Country (2017-2028)
Figure 56. Latin America Follicle Stimulating Hormone Revenue Share by Country (2017-2028)
Figure 57. Middle East and Africa Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
Figure 58. Middle East and Africa Follicle Stimulating Hormone Revenue Market Share by Type (2017-2028)
Figure 59. Middle East and Africa Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
Figure 60. Middle East and Africa Follicle Stimulating Hormone Revenue Market Share by Application (2017-2028)
Figure 61. Middle East and Africa Follicle Stimulating Hormone Sales Share by Country (2017-2028)
Figure 62. Middle East and Africa Follicle Stimulating Hormone Revenue Share by Country (2017-2028)
Figure 63. Follicle Stimulating Hormone Value Chain
Figure 64. Follicle Stimulating Hormone Production Process
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck Serono MSD IBSA Ferring Livzon Techwell GenSci Gedeon Richter Teva